X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
82
PharmaCompass offers a list of Diatrizoic Acid Dihydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diatrizoic Acid Dihydrate manufacturer or Diatrizoic Acid Dihydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diatrizoic Acid Dihydrate manufacturer or Diatrizoic Acid Dihydrate supplier.
PharmaCompass also assists you with knowing the Diatrizoic Acid Dihydrate API Price utilized in the formulation of products. Diatrizoic Acid Dihydrate API Price is not always fixed or binding as the Diatrizoic Acid Dihydrate Price is obtained through a variety of data sources. The Diatrizoic Acid Dihydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diatrizoic Acid Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diatrizoic Acid Dihydrate, including repackagers and relabelers. The FDA regulates Diatrizoic Acid Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diatrizoic Acid Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diatrizoic Acid Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diatrizoic Acid Dihydrate supplier is an individual or a company that provides Diatrizoic Acid Dihydrate active pharmaceutical ingredient (API) or Diatrizoic Acid Dihydrate finished formulations upon request. The Diatrizoic Acid Dihydrate suppliers may include Diatrizoic Acid Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diatrizoic Acid Dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diatrizoic Acid Dihydrate active pharmaceutical ingredient (API) in detail. Different forms of Diatrizoic Acid Dihydrate DMFs exist exist since differing nations have different regulations, such as Diatrizoic Acid Dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diatrizoic Acid Dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Diatrizoic Acid Dihydrate USDMF includes data on Diatrizoic Acid Dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diatrizoic Acid Dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with USDMF on PharmaCompass.
A Diatrizoic Acid Dihydrate CEP of the European Pharmacopoeia monograph is often referred to as a Diatrizoic Acid Dihydrate Certificate of Suitability (COS). The purpose of a Diatrizoic Acid Dihydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diatrizoic Acid Dihydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diatrizoic Acid Dihydrate to their clients by showing that a Diatrizoic Acid Dihydrate CEP has been issued for it. The manufacturer submits a Diatrizoic Acid Dihydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diatrizoic Acid Dihydrate CEP holder for the record. Additionally, the data presented in the Diatrizoic Acid Dihydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diatrizoic Acid Dihydrate DMF.
A Diatrizoic Acid Dihydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diatrizoic Acid Dihydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with CEP (COS) on PharmaCompass.
A Diatrizoic Acid Dihydrate written confirmation (Diatrizoic Acid Dihydrate WC) is an official document issued by a regulatory agency to a Diatrizoic Acid Dihydrate manufacturer, verifying that the manufacturing facility of a Diatrizoic Acid Dihydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diatrizoic Acid Dihydrate APIs or Diatrizoic Acid Dihydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Diatrizoic Acid Dihydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diatrizoic Acid Dihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diatrizoic Acid Dihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diatrizoic Acid Dihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diatrizoic Acid Dihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diatrizoic Acid Dihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with NDC on PharmaCompass.
Diatrizoic Acid Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diatrizoic Acid Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diatrizoic Acid Dihydrate GMP manufacturer or Diatrizoic Acid Dihydrate GMP API supplier for your needs.
A Diatrizoic Acid Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Diatrizoic Acid Dihydrate's compliance with Diatrizoic Acid Dihydrate specifications and serves as a tool for batch-level quality control.
Diatrizoic Acid Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Diatrizoic Acid Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diatrizoic Acid Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diatrizoic Acid Dihydrate EP), Diatrizoic Acid Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diatrizoic Acid Dihydrate USP).
Market Place
